HBA salutes Bayer effort to bolster women leaders

Share this article:

Bayer HealthCare was awarded the Healthcare Businesswomen's Association (HBA) ACE Award in recognition of its Women's Leadership Initiative. 

The award recognizes "leadership programs that perform, specifically demonstrating excellence in business performance, stewardship, execution, sustainability and measureable results." 

Bayer's two-year-old Women's Leadership Initiative aims to cultivate women leaders through networking opportunities, educational and mentoring programs, tools and other resources for female managers within the company.

“Bayer HealthCare's WLI clearly demonstrates a strong commitment to fostering the leadership development of women, which will have a direct impact on the healthcare industry,” said HBA President Deborah Coogan Seltzer. “We are proud that the ACE Award is recognizing this effort.”

The award will be presented Thursday at HBA's 2011 Leadership Conference in Washington, DC.


Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...